To help independent pharmacy owners better understand the fast-growing, uber-complex specialty pharmacy business, the National Community Pharmacists Association last month hosted a day-long forum, “Exploring the intersection of specialty medications, community pharmacy and patient care.”
How serious are Rite Aid’s leaders when they proclaim their determination to make the company a full-service, full-spectrum retail healthcare provider? Serious enough to buy RediClinic — which has operated walk-in healthcare clinics in roughly 30 H-E-B stores in Texas for much of the past decade — and serious enough to embark on an aggressive growth campaign that includes the clinic healthcare provider as a new Rite Aid subsidiary.
Rite Aid is back — and in a very big way. After years of toiling in the shadows of its fast-growing and better-capitalized rivals, the company has regained its footing and market momentum with a renewed vitality and a sharply defined focus on its mission as a community-driven health-and-wellness retailer.
More and more, the success of any healthcare delivery model in the United States will depend on the ability of all members of a patient-care team — physicians, pharmacists, hospital systems and health plan payers included — to collaborate effectively on a longterm plan of care that’s focused on successful outcomes and disease prevention.
Congress, Medicare and industry stakeholders should strike the right balance to cut out fraud in the Medicare Part D drug program while preserving patient access to critical medications, the National Community Pharmacists Association stated in comments submitted in conjunction with a House Energy and Commerce subcommittee hearing Tuesday on the topic.
On the occasion of the 2015 White House Conference on Aging, which marks the sixth such event since the first in 1961, National Association of Chain Drug Stores president and CEO Steve Anderson joined the dialogue by issuing a statement.
The average lost time worker's compensation claim for workers using opioid painkillers can total as much as $117,000 — 900% higher than the cost for workers who do not take opioid painkillers, the National Safety Council says.